FindTrial
Sign In

Efficacy and Safety of Colistin in the Treatment of serious Infections in Patients with hematological diseases: A Single-center Retrospective Study

Efficacy and Safety of Colistin in the Treatment of serious Infections in Patients with hematological diseases: A Single-center Retrospective Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300078390
Enrollment
Unknown
Registered
2023-12-07
Start date
2023-12-10
Completion date
Unknown
Last updated
2023-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hematological disease

Interventions

Case series:None

Sponsors

First Affiliated Hospital of Soochow University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
15 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1) Hospitalized ICU patients with hematological diseases complicated with severe infections 2) Patients who receive polymyxin therapy after admission, as assessed by clinical physicians

Exclusion criteria

Exclusion criteria: 1) Non hematological inpatients 2) Not using polymyxin antibiotics

Design outcomes

Primary

MeasureTime frame
Clinical efficiency;—

Secondary

MeasureTime frame
All cause mortality;Bacterial clearance rate;mechanical ventilation time;Hospitalization days;the incidence of acute kidney injury;—

Countries

China

Contacts

Public ContactJianhong Fu

First Affiliated Hospital of Soochow University

fujianhong@suda.edu.cn+86 186 6218 2582

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026